Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Ampyra1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2Dalfampridine
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
3Dalfampridine ER
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
4Dalfampridine ER, 10 MG oral tablet, extended release
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
5Dalfampridine plus physical therapy
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
6Dalfampridine-ER 10MG
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
7Dalfampridine-ER 5MG
(Ampyra, AMPYRA)		1件: Dalfampridine1件: Dalfampridine (Ampyra, AMPYRA) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
8Sustained-release oral dalfampridine
(Ampyra, AMPYRA)		----1件: 13 💬
9Withdrawal OF dalfampridine-ER 10MG
(Ampyra, AMPYRA)		----1件: 13 💬